Kiniksa Pharmaceuticals International, plc (KNSA)

SEC filing

Kiniksa Pharmaceuticals International, plc

KNSA · CIK 1730430

4 · Sep 3, 2026 · CHIEF MEDICAL OFFICER Paolini John F. exercised options for 16.66K shares; was granted 33.45K shares; reported 4,029 Class A Ordinary Share

CHIEF MEDICAL OFFICER Paolini John F. exercised options for 16.66K shares; was granted 33.45K shares; reported 4,029 Class A Ordinary Share

Filed: Sep 3, 2026
Period: Sep 1, 2026
Accession: 0001741533-26-000010
Filer: Kiniksa Pharmaceuticals International, plc

View on SEC.gov All SEC filings

Filing document

xslF345X06/form4-09032026_080907.xml

xslF345X06/form4-09032026_080907.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4form4-09032026_080907.xml
Open SEC.gov